Does NIVOLUMAB Cause Transaminases increased? 286 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 286 reports of Transaminases increased have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
286
Reports of Transaminases increased with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
42
Deaths
176
Hospitalizations
How Dangerous Is Transaminases increased From NIVOLUMAB?
Of the 286 reports, 42 (14.7%) resulted in death, 176 (61.5%) required hospitalization, and 21 (7.3%) were considered life-threatening.
Is Transaminases increased Listed in the Official Label?
Yes, Transaminases increased is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Transaminases increased?
METHOTREXATE (1,236)
ACETAMINOPHEN (929)
ATORVASTATIN (472)
RITUXIMAB (448)
CYCLOPHOSPHAMIDE (401)
PREDNISONE (362)
ADALIMUMAB (340)
PACLITAXEL (333)
ROSUVASTATIN (324)
CARBOPLATIN (319)
Which NIVOLUMAB Alternatives Have Lower Transaminases increased Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE